11 beta-hydroxyandrostenedione in human amniotic fluid
Language English Country Germany Media print
Document type Journal Article
PubMed
2083574
DOI
10.1055/s-0029-1211028
Knihovny.cz E-resources
- MeSH
- Androstenedione analogs & derivatives analysis MeSH
- Adrenal Hyperplasia, Congenital diagnosis MeSH
- Humans MeSH
- Amniotic Fluid chemistry MeSH
- Prenatal Diagnosis MeSH
- Reference Values MeSH
- Pregnancy MeSH
- Check Tag
- Humans MeSH
- Male MeSH
- Pregnancy MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Names of Substances
- 11-hydroxyandrostenedione MeSH Browser
- Androstenedione MeSH
11 beta-Hydroxyandrostene-3,17-dione (11 beta-hydroxyandrostenedione), a potential marker for prenatal diagnosis of CAH, has been for the first time determined in amniotic fluid obtained from 68 women who later delivered children without endocrine disorders. Its concentration averaged 0.96 +/- 0.31 (S.D.) (range 0.48-1.85) nmol/l and did not depend on the fetal sex. There was mild, insignificant increase of these values along with duration of pregnancy.
References provided by Crossref.org
